Blue Apron stock has lost nearly 80 percent of its value since going public.
And Inc. reporter Zoe Henry told Cheddar that, if the meal-kit company wants to compete in an increasingly crowded space, it has to funnel more money into its marketing strategy and serve more niche audiences.
“Maybe they need to be offering different types of meals. Maybe vegan, maybe vegetarian, or sourced-locally,” she said Friday. “They need to do a little bit more of what the Sun Baskets of the world are doing.”
Shares of Blue Apron rebounded slightly Friday, after news Weight Watchers is entering the space sent them plunging more than 16 percent a day earlier.
And that’s just the latest blow. If the myriad of pure-play companies in field -- from Sun Basket to HelloFresh to Purple Carrot -- weren’t enough, earlier in the week even Walmart announced plans to offer meal-prep kits.
Competition from lower-priced rivals like that could be a real problem for the company.
“New York and San Francisco yuppies could only take you so far, so we’re going to need to expand beyond the upper middle class millennial market,” she said. “Try telling a mom of four in Barlow, Ohio, that she needs to spend however much a month on Blue Apron, when she could just run to Walgreens or the dollar store and buy cheaper products for dinner that night.”
For the full interview, [click here](https://cheddar.com/videos/blue-apron-stock-hits-record-low-with-weight-watchers-announcement).
Meridith McGraw, White House Reporter at The Wall Street Journal, breaks down Trump’s $200M ballroom plan, D.C. police tensions, and the future of MAGA.
After years of being told that red wine was good for heart health, more Americans appear to be heeding warnings that even moderate alcohol consumption can be unhealthy.
Amazon is now rolling out a service where its Prime members can order their blueberries and milk at the same time as their batteries and other basic items.
Dr. Richard Besser, President & CEO of the Robert Wood Johnson Foundation and former CDC acting director, unpacks the impact of RFK's mRNA funding cuts.
Jessica Inskip, Director of Investor Research at StockBrokers.com and host of MarketMakeHer, unpacks earnings, market outlook, and what history says is next.
